Vyrix Pharmaceuticals Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Merger of Eq.
  • Financing Rounds
  • 2

Vyrix Pharmaceuticals General Information

Description

Developer of pharmaceutical products. The company engages in developing and commercializing late-stage prescription pharmaceuticals. It develops Zertane™, an oral drug in late stage development as a proprietary treatment for premature ejaculation. It is also developing a combination product with Zertane and an erectile dysfunction product to address co-morbid PE and erectile dysfunction.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 5445 DTC Parkway
  • Suite 925
  • Greenwood Village, CO 80111
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vyrix Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vyrix Pharmaceuticals‘s full profile, request access.

Request a free trial

Vyrix Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vyrix Pharmaceuticals‘s full profile, request access.

Request a free trial